493 related articles for article (PubMed ID: 23992479)
21. The sputum microbiome is distinct between COPD and health, independent of smoking history.
Haldar K; George L; Wang Z; Mistry V; Ramsheh MY; Free RC; John C; Reeve NF; Miller BE; Tal-Singer R; Webb AJ; Brookes AJ; Tobin MD; Singh D; Donaldson GC; Wedzicha JA; Brown JR; Barer MR; Brightling CE
Respir Res; 2020 Jul; 21(1):183. PubMed ID: 32664956
[TBL] [Abstract][Full Text] [Related]
22. Sputum Microbiome Dynamics in Chronic Obstructive Pulmonary Disease Patients during an Exacerbation Event and Post-Stabilization.
López Caro JC; Santibáñez M; García Rivero JL; Villanueva M; Sainz J; González Astorqui P; Hierro M; Rodríguez Porres M; Paras Bravo P; Mira A; Rodriguez JC; Galiana A;
Respiration; 2019; 98(5):447-454. PubMed ID: 31437842
[TBL] [Abstract][Full Text] [Related]
23. Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa.
Millares L; Ferrari R; Gallego M; Garcia-Nuñez M; Pérez-Brocal V; Espasa M; Pomares X; Monton C; Moya A; Monsó E
Eur J Clin Microbiol Infect Dis; 2014 Jul; 33(7):1101-11. PubMed ID: 24449346
[TBL] [Abstract][Full Text] [Related]
24. Chronic obstructive pulmonary disease upper airway microbiome is associated with select clinical characteristics.
Pragman AA; Knutson KA; Gould TJ; Hodgson SW; Isaacson RE; Reilly CS; Wendt CH
PLoS One; 2019; 14(7):e0219962. PubMed ID: 31335912
[TBL] [Abstract][Full Text] [Related]
25. Antagonistic Pleiotropy in the Bifunctional Surface Protein FadL (OmpP1) during Adaptation of Haemophilus influenzae to Chronic Lung Infection Associated with Chronic Obstructive Pulmonary Disease.
Moleres J; Fernández-Calvet A; Ehrlich RL; Martí S; Pérez-Regidor L; Euba B; Rodríguez-Arce I; Balashov S; Cuevas E; Liñares J; Ardanuy C; Martín-Santamaría S; Ehrlich GD; Mell JC; Garmendia J
mBio; 2018 Sep; 9(5):. PubMed ID: 30254117
[TBL] [Abstract][Full Text] [Related]
26. Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease.
Diao W; Shen N; Du Y; Erb-Downward JR; Sun X; Guo C; Ke Q; Huffnagle GB; Gyetko MR; He B
Int J Chron Obstruct Pulmon Dis; 2018; 13():2289-2299. PubMed ID: 30104869
[TBL] [Abstract][Full Text] [Related]
27. Human Rhinovirus Impairs the Innate Immune Response to Bacteria in Alveolar Macrophages in Chronic Obstructive Pulmonary Disease.
Finney LJ; Belchamber KBR; Fenwick PS; Kemp SV; Edwards MR; Mallia P; Donaldson G; Johnston SL; Donnelly LE; Wedzicha JA
Am J Respir Crit Care Med; 2019 Jun; 199(12):1496-1507. PubMed ID: 30562053
[No Abstract] [Full Text] [Related]
28. Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease.
Garcia-Nuñez M; Millares L; Pomares X; Ferrari R; Pérez-Brocal V; Gallego M; Espasa M; Moya A; Monsó E
J Clin Microbiol; 2014 Dec; 52(12):4217-23. PubMed ID: 25253795
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the bacterial community in chronic obstructive pulmonary disease sputum samples by denaturing gradient gel electrophoresis and real-time PCR.
Wu D; Hou C; Li Y; Zhao Z; Liu J; Lu X; Shang X; Xin Y
BMC Pulm Med; 2014 Nov; 14():179. PubMed ID: 25403149
[TBL] [Abstract][Full Text] [Related]
30. Antiviral immunity is impaired in COPD patients with frequent exacerbations.
Singanayagam A; Loo SL; Calderazzo M; Finney LJ; Trujillo Torralbo MB; Bakhsoliani E; Girkin J; Veerati P; Pathinayake PS; Nichol KS; Reid A; Footitt J; Wark PAB; Grainge CL; Johnston SL; Bartlett NW; Mallia P
Am J Physiol Lung Cell Mol Physiol; 2019 Dec; 317(6):L893-L903. PubMed ID: 31513433
[TBL] [Abstract][Full Text] [Related]
31. Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function.
Bafadhel M; Haldar K; Barker B; Patel H; Mistry V; Barer MR; Pavord ID; Brightling CE
Int J Chron Obstruct Pulmon Dis; 2015; 10():1075-83. PubMed ID: 26089657
[TBL] [Abstract][Full Text] [Related]
32. Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study.
Wang Z; Singh R; Miller BE; Tal-Singer R; Van Horn S; Tomsho L; Mackay A; Allinson JP; Webb AJ; Brookes AJ; George LM; Barker B; Kolsum U; Donnelly LE; Belchamber K; Barnes PJ; Singh D; Brightling CE; Donaldson GC; Wedzicha JA; Brown JR;
Thorax; 2018 Apr; 73(4):331-338. PubMed ID: 29269441
[TBL] [Abstract][Full Text] [Related]
33. Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease.
Singh M; Lee SH; Porter P; Xu C; Ohno A; Atmar RL; Greenberg SB; Bandi V; Gern J; Amineva S; Aminev A; Skern T; Smithwick P; Perusich S; Barrow N; Roberts L; Corry DB; Kheradmand F
J Allergy Clin Immunol; 2010 Jun; 125(6):1369-1378.e2. PubMed ID: 20430426
[TBL] [Abstract][Full Text] [Related]
34. Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD.
Quint JK; Donaldson GC; Goldring JJ; Baghai-Ravary R; Hurst JR; Wedzicha JA
Chest; 2010 Apr; 137(4):812-22. PubMed ID: 19837822
[TBL] [Abstract][Full Text] [Related]
35. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.
Molyneaux PL; Cox MJ; Willis-Owen SA; Mallia P; Russell KE; Russell AM; Murphy E; Johnston SL; Schwartz DA; Wells AU; Cookson WO; Maher TM; Moffatt MF
Am J Respir Crit Care Med; 2014 Oct; 190(8):906-13. PubMed ID: 25184687
[TBL] [Abstract][Full Text] [Related]
36. Association between pathogens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable state and exacerbations.
Barker BL; Haldar K; Patel H; Pavord ID; Barer MR; Brightling CE; Bafadhel M
Chest; 2015 Jan; 147(1):46-55. PubMed ID: 25103335
[TBL] [Abstract][Full Text] [Related]
37. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
[TBL] [Abstract][Full Text] [Related]
38. Sputum Microbiome Is Associated with 1-Year Mortality after Chronic Obstructive Pulmonary Disease Hospitalizations.
Leitao Filho FS; Alotaibi NM; Ngan D; Tam S; Yang J; Hollander Z; Chen V; FitzGerald JM; Nislow C; Leung JM; Man SFP; Sin DD
Am J Respir Crit Care Med; 2019 May; 199(10):1205-1213. PubMed ID: 30376356
[No Abstract] [Full Text] [Related]
39. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.
Dicker AJ; Huang JTJ; Lonergan M; Keir HR; Fong CJ; Tan B; Cassidy AJ; Finch S; Mullerova H; Miller BE; Tal-Singer R; Chalmers JD
J Allergy Clin Immunol; 2021 Jan; 147(1):158-167. PubMed ID: 32353489
[TBL] [Abstract][Full Text] [Related]
40. Resistome analyses of sputum from COPD and healthy subjects reveals bacterial load-related prevalence of target genes.
Ramsheh MY; Haldar K; Bafadhel M; George L; Free RC; John C; Reeve NF; Ziegler-Heitbrock L; Gut I; Singh D; Mistry V; Tobin MD; Oggioni MR; Brightling C; Barer MR
Thorax; 2020 Jan; 75(1):8-16. PubMed ID: 31699806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
